Halozyme Therapeutics Inc (NASDAQ:HALO)

17.67
BATS BZX Real-Time Price
As of 2:39pm ET
 -0.15 / -0.84%
Today’s Change
7.51
Today|||52-Week Range
18.18
+83.11%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Halozyme Therapeutics Inc have a median target of 20.00, with a high estimate of 26.00 and a low estimate of 6.00. The median estimate represents a +13.19% increase from the last price of 17.67.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Halozyme Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.12
Sales
$22.0M
Reporting Date
Aug 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 1.98%
 
 
 
 
 
 
Growthannually 15.68%
 
 
 
 
 
 

Sales

Growthquarterly 17.87%
 
 
 
 
 
 
Growthannually 22.81%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account